Axon Enterprise, Inc $AXON Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. decreased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXONFree Report) by 24.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 6,944 shares of the biotechnology company’s stock after selling 2,231 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Axon Enterprise were worth $4,983,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of AXON. Stone House Investment Management LLC purchased a new stake in shares of Axon Enterprise during the 3rd quarter valued at $29,000. Whipplewood Advisors LLC raised its position in shares of Axon Enterprise by 192.9% in the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after buying an additional 27 shares during the period. Root Financial Partners LLC acquired a new position in Axon Enterprise in the third quarter valued at $34,000. Darwin Wealth Management LLC purchased a new stake in Axon Enterprise during the second quarter valued at about $37,000. Finally, NewSquare Capital LLC increased its stake in Axon Enterprise by 96.2% during the second quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock worth $42,000 after acquiring an additional 25 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Down 2.8%

NASDAQ AXON opened at $434.45 on Thursday. The stock has a market cap of $34.28 billion, a P/E ratio of 137.48, a PEG ratio of 13.46 and a beta of 1.48. The company’s fifty day simple moving average is $562.29 and its 200-day simple moving average is $652.35. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57. Axon Enterprise, Inc has a 52 week low of $396.41 and a 52 week high of $885.91.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. The Goldman Sachs Group reduced their price objective on Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a research note on Wednesday, November 5th. Piper Sandler reduced their price target on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Barclays dropped their price objective on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a research report on Thursday, November 6th. William Blair reissued an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 3rd. Finally, Wall Street Zen cut shares of Axon Enterprise from a “hold” rating to a “sell” rating in a research report on Saturday, November 8th. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $805.71.

Get Our Latest Stock Report on AXON

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, CAO Jennifer H. Mak sold 1,134 shares of the company’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $600.00, for a total value of $680,400.00. Following the completion of the transaction, the chief accounting officer directly owned 13,740 shares of the company’s stock, valued at $8,244,000. This represents a 7.62% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $552.60, for a total value of $11,052,000.00. Following the sale, the president directly owned 249,502 shares in the company, valued at approximately $137,874,805.20. The trade was a 7.42% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 48,040 shares of company stock worth $27,249,338 over the last three months. Insiders own 4.40% of the company’s stock.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.